Results 171 to 180 of about 56,990 (293)

Understanding health services and puberty for autistic adolescents and those with disability: A scoping review to inform occupational therapy practice

open access: yesAustralian Occupational Therapy Journal, Volume 73, Issue 2, April 2026.
Abstract Introduction Puberty is a transitional period presenting challenges for autistic adolescents, adolescents with disabilities and their families. There are opportunities for occupational therapy to provide support to this cohort as adolescents navigate the complexity of puberty transition.
Sarah Hausler   +2 more
wiley   +1 more source

Ultrasound‐Guided Ovulation Monitoring Versus Home Ovulation Tests and Psychosocial Outcomes in Subfertile Couples: Prospective Cohort Study

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 5, Page 996-1005, April 2026.
ABSTRACT Objective To assess whether ultrasound‐guided ovulation monitoring, compared to home ovulation tests, increases stress levels or impairs sexual function in subfertile couples. Design A prospective cohort study. Setting Academic medical centre from November 2023 to October 2024.
Yueying Zhu   +5 more
wiley   +1 more source

A Manifesto for Universal Healthcare: Reconstituting Primary Care Through Digital Innovation, Microbial Technologies and Empowered Citizenship

open access: yesMicrobial Biotechnology, Volume 19, Issue 4, April 2026.
Despite unprecedented medical advances, global healthcare is failing to deliver universal, equitable and quality care, vulnerable to surges in demand, and unsustainable. Here we describe a self‐reinforcing framework for rebuilding equitable and resilient health systems.
Kenneth Timmis   +4 more
wiley   +1 more source

Safety and Efficacy Assessment of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2‐Positive Unresectable Locally Advanced or Metastatic Breast Cancer Previously Treated With Trastuzumab and a Taxane: An Open‐Label, Single‐Arm, Phase IV Study

open access: yesAsia-Pacific Journal of Clinical Oncology, Volume 22, Issue 2, Page 240-250, April 2026.
A phase IV, single‐arm, open‐label, multicenter study assessing the safety and efficacy of trastuzumab emtansine in Indian patients for the treatment of human epidermal growth factor receptor 2 (HER2)‐positive unresectable locally advanced or metastatic breast cancer who received prior treatment with trastuzumab and a taxane.
Sudeep Gupta   +13 more
wiley   +1 more source

Factors Associated With Pain Related to Insertion of a Contraceptive Intrauterine Device: Findings of a National Survey

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 2, April 2026.
ABSTRACT Background A prominent barrier to broader intrauterine device (IUD) uptake is the fear of pain and discomfort associated with insertion of the device. Aim To examine the pain level perceived during IUD insertion and identify factors associated with perceived pain during the insertion procedure.
Vera Camões‐Costa   +4 more
wiley   +1 more source

Management of Gynaecological Chronic Pelvic Pain in the Emergency Setting— A Scoping Review

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 2, April 2026.
ABSTRACT Background Gynaecological chronic pelvic pain (CPP) has a high prevalence among adult women. This pain can be debilitating and life‐impacting, affecting quality of life across all dimensions of health. Many barriers to specialised care exist, leading women to rely on unscheduled general care like emergency departments or in the out‐of‐hospital.
Lucinda Peacock   +5 more
wiley   +1 more source

Trends in Government‐Subsidised Menopausal Hormone Therapy Dispensing in Australia Between 2014 and 2023

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 2, April 2026.
ABSTRACT Menopausal hormone therapy (MHT) is a mainstay treatment for menopausal symptoms. While international studies report rising MHT use, trends in Australia remain unclear. Using a 10% random sample of Pharmaceutical Benefits Scheme (PBS) data from 2014 to 2023, we analysed the prevalence of MHT dispensing among women aged 45–64.
Hindun Wilda Risni   +5 more
wiley   +1 more source

Issue Information

open access: yes
Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 5, Page 763-765, May 2026.
wiley   +1 more source

Induced abortion, miscarriage, and the risk of breast cancer—A registry‐based study from Finland

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 4, Page 596-603, April 2026.
The history of induced abortion or miscarriage is not associated with an increased risk of either pre‐ or postmenopausal breast cancer. Abstract Introduction The potential effect of induced abortion and miscarriage on the risk of breast cancer has remained debated and has been a persistent source of misinformation. Many previous studies have been small
Sushmita Katuwal   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy